Meeting of the Chronic Fatigue Syndrome Advisory Committee, 69853-69854 [2013-27926]
Download as PDF
Federal Register / Vol. 78, No. 225 / Thursday, November 21, 2013 / Notices
Governors not later than December 16,
2013.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Cistern, LLC and Flatonia
Investments, LLC, both in Houston,
Texas; to become bank holding
companies by acquiring 100 percent of
the voting shares of The Columbia
Savings Bank, Cincinnati, Ohio.
Board of Governors of the Federal Reserve
System, November 18, 2013.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2013–27923 Filed 11–20–13; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Group on
Prevention, Health Promotion, and
Integrative and Public Health
Office of the Surgeon General
of the United States Public Health
Service, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
In accordance with Section
10(a) of the Federal Advisory Committee
Act, Public Law 92–463, as amended (5
U.S.C. App.), notice is hereby given that
a meeting is scheduled to be held for the
Advisory Group on Prevention, Health
Promotion, and Integrative and Public
Health (the ‘‘Advisory Group’’). The
meeting will be open to the public.
Information about the Advisory Group
and the agenda for this meeting can be
obtained by accessing the following
Web site: https://
www.surgeongeneral.gov/initiatives/
prevention/advisorygrp/.
DATES: The meeting will be held on
December 11, 2013 from 3:00–5:00 p.m.
EST via teleconference. More
information can be found at: https://
www.surgeongeneral.gov/initiatives/
prevention/advisorygrp/.
FOR FURTHER INFORMATION CONTACT:
Office of the Surgeon General, 200
Independence Ave. SW.; Hubert H.
Humphrey Building, Room 701H;
Washington, DC 20201; 202–205–9517;
prevention.council@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Group is a non-discretionary
federal advisory committee that was
initially established under Executive
Order 13544, dated June 10, 2010, to
comply with the statutes under Section
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:17 Nov 20, 2013
Jkt 232001
4001 of the Patient Protection and
Affordable Care Act, Public Law 111–
148. Under Executive Order 13591,
dated November 23, 2011, operation of
the Advisory Group was terminated on
September 30, 2012. On December 7,
2012, President Obama issued Executive
Order 13631 to re-establish the Advisory
Group until September 30, 2013.
Authorization for the Advisory Group to
continue to operate until September 30,
2015, was given under Executive Order
13652, dated September 30, 2013. The
Advisory Group was established to
assist in carrying out the mission of the
National Prevention, Health Promotion,
and Public Health Council (the
Council). The Advisory Group provides
recommendations and advice to the
Council.
It is authorized for the Advisory
Group to consist of not more than 25
non-federal members. The Advisory
Group currently has 22 members who
were appointed by the President. The
membership includes a diverse group of
licensed health professionals, including
integrative health practitioners who
have expertise in (1) worksite health
promotion; (2) community services,
including community health centers; (3)
preventive medicine; (4) health
coaching; (5) public health education;
(6) geriatrics; and (7) rehabilitation
medicine. Topics of discussion for the
December 2013 meeting of the Advisory
Group include an update from the
National Prevention Council; discussion
of the Education and Health Working
Group recommendations; and
discussion of the draft report to the
Surgeon General.
Members of the public who wish to
attend must register by 12:00 p.m. EST
on December 4, 2013. Individuals
should register for public attendance at
prevention.council@hhs.gov by
providing your full name and affiliation.
The public will have the opportunity to
provide comments to the Advisory
Group; public comment will be limited
to 3 minutes per speaker. Registration
through the designated contact for the
public comment session is also
required. Any member of the public
who wishes to have printed materials
distributed to the Advisory Group for
this scheduled meeting should submit
material to the designed point of contact
no later than 12:00 p.m. EST on
December 4, 2013.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
69853
Dated: November 4, 2013.
Corinne M. Graffunder,
Designated Federal Officer, Advisory Group
on Prevention, Health Promotion, and
Integrative and Public Health, Office of the
Surgeon General.
[FR Doc. 2013–27927 Filed 11–20–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Chronic Fatigue
Syndrome Advisory Committee
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting of the Chronic Fatigue
Syndrome Advisory Committee
(CFSAC) will take place via webinar.
This webinar meeting will be open to
the public. The webinar will include
public comment session(s). Registration
is required in advance for both public
participants and comment. Any
individual who wishes to participate in
the public meeting and/or in the public
comment session should register at
www.blsmeetings.net/CFSACdec2013/.
DATES: The webinar meeting will be
held on Tuesday, December 10, 2013
and Wednesday, December 11, 2013
from 12:00 p.m. until 5:00 p.m. (EST) on
both days.
ADDRESSES: The meeting will be
conducted by webinar.
FOR FURTHER INFORMATION CONTACT:
Nancy C. Lee, M.D., Designated Federal
Officer, Chronic Fatigue Syndrome
Advisory Committee, Department of
Health and Human Services, Office on
Women’s Health, 200 Independence
Avenue SW., Room 712E, Washington,
DC 20201. Phone: 202–690–7650; Fax:
202–401–4005. cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: The
CFSAC is authorized under 42 U.S.C.
217a, Section 222 of the Public Health
Service Act, as amended. The purpose
of the CFSAC is to provide advice and
recommendations to the Secretary of
Health and Human Services, through
the Assistant Secretary for Health
(ASH), on issues related to chronic
fatigue syndrome (CFS). The issues can
include factors affecting access and care
for persons with CFS; the science and
definition of CFS; and broader public
health, clinical, research and
educational issues related to CFS.
SUMMARY:
E:\FR\FM\21NON1.SGM
21NON1
tkelley on DSK3SPTVN1PROD with NOTICES
69854
Federal Register / Vol. 78, No. 225 / Thursday, November 21, 2013 / Notices
The agenda for this meeting is being
developed and will be posted on the
CFSAC Web site www.hhs.gov/
advocomcfsac and at
www.blsmeetings.net/CFSACdec2013/.
The webinar will be a ‘‘virtual meeting’’
using Adobe Acrobat Connect Pro
Meeting, a Web conferencing product
that allows users to conduct live
meetings and presentations over the
Internet.
Using Adobe Connect Pro Meeting
software requires that you have an
Internet connection, a Web browser, and
the latest version of Adobe Flash Player
to participate in the webinar. Adobe
Connect Pro is supported by many
operating systems, including Windows,
Macintosh, Linux, and Solaris as well as
the most widely used browsers,
including Internet Explorer, Firefox, and
Safari.
We recommend that you test your
computer prior to participation. You can
do this by going to https://
admin.adobeconnect.com/common/
help/en/support/meeting_test.htm.
Instructions for accessing the webinar
will be available at:
www.blsmeetings.net/CFSACdec2013/
webinarinformation.cfm.
This webinar will be limited to 500
participants. All individuals who want
to view the webinar will need to
register. You will receive instructions
for accessing the webinar after you
register. Members of the public will
have the opportunity to provide public
comment during the meeting via
telephone, pre-recorded video, or
written comments. Registration is
required in advance in order to submit
public comments. An individual who
would like to present comments should
note this when completing the
registration form. The deadline to
register and submit public comments is
Friday, November 29, 2013. We will
confirm your time for public comment
via email by December 4, 2013. Please
refer to the agenda for scheduled public
comment periods. Each speaker via
telephone or pre-recorded video will be
limited to five minutes. We will give
priority to individuals who have not
provided public comment within the
past 12 months. We will be unable to
place international calls for public
comments. We can accept written or
prerecorded video testimony from
international locations. Further details
are available at www.blsmeetings.net/
CFSACdec2013/publicComments.cfm.
Only testimony submitted for public
comment and received in advance of the
meeting are part of the official meeting
record and will be posted to the CFSAC
Web site. Materials submitted should
not include sensitive personal
VerDate Mar<15>2010
17:17 Nov 20, 2013
Jkt 232001
information, such as social security
number, birthdates, driver’s license
number, state identification or foreign
country equivalent, passport number,
financial account number, or credit or
debit card number. If you wish to
remain anonymous the document must
specify this.
Dated: November 18, 2013.
Nancy C. Lee,
Designated Federal Officer, Chronic Fatigue
Syndrome Advisory Committee, U.S.
Department of Health and Human Services.
[FR Doc. 2013–27926 Filed 11–20–13; 8:45 am]
BILLING CODE 4150–42–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–14–13ZJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Emergency Epidemic Investigation
Data Collections—New—Center for
Surveillance, Epidemiology, and
Laboratory Services (CSELS), Division
of Scientific Education and Professional
Development, DSEPD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC previously has conducted
Emergency Epidemic Investigations
(EEIs) under Office of Management and
Budget (OMB) control number 0920–
0008. CDC is seeking a new OMB
generic clearance for a 3-year period to
collect vital information during EEIs in
response to urgent outbreaks or events
(i.e., natural, biological, chemical,
nuclear, radiological) characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors. These EEIs
represent a subset of those performed
under OMB clearance 0920–0008.
Supporting effective emergency
epidemic investigations is one of the
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
most important ways that CDC protects
the health of the public. CDC is
frequently called upon to conduct EEIs
at the request of local, state, or
international health authorities seeking
support to respond to urgent outbreaks
or urgent public health-related events.
In response to external partner requests,
CDC provides necessary epidemiologic
support to identify the agents, sources,
modes of transmission, or risk factors to
effectively implement rapid prevention
and control measures to protect the
public’s health. Data collection is a
critical component of the epidemiologic
support provided by CDC; data are
analyzed to determine the agents,
sources, modes of transmission, or risk
factors so that effective prevention and
control measures can be implemented.
During an unanticipated outbreak or
event, immediate action by CDC is
necessary to minimize or prevent public
harm. The legal justification for EEIs are
found in the Public Health Service Act
(42 U.S.C. Sec. 301 [241](a)).
Successful investigations are
dependent on rapid and flexible data
collection that evolves during the
investigation and is customized to the
unique circumstances of each outbreak
or event. Data collection elements will
be those necessary to identify the
agents, sources, mode of transmission,
or risk factors. Examples of potential
data collection methods include
telephone or face-to-face interview;
email, Web or other type of electronic
questionnaire; paper-and-pencil
questionnaire; focus groups; medical
record review; laboratory record review;
collection of clinical samples; and
environmental assessment. Respondents
will vary depending on the nature of the
outbreak or event; examples of potential
respondents include health care
professionals, patients, laboratorians,
and the general public. Participation in
EEIs is voluntary and there are no
anticipated costs to respondents other
than their time. CDC will use the
information gathered during EEIs to
rapidly identify and effectively
implement measures to minimize or
prevent public harm.
CDC projects 60 EEIs in response to
outbreaks or events characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors annually. The
projected average number of
respondents is 200 per EEI, for a total
of 12,000 respondents. CDC estimates
the average burden per response is 0.5
hours and each respondent will be
asked to respond once. Therefore, the
total estimated annual burden hours are
6,000. These estimates are based on the
reported burden for EEIs that have been
E:\FR\FM\21NON1.SGM
21NON1
Agencies
[Federal Register Volume 78, Number 225 (Thursday, November 21, 2013)]
[Notices]
[Pages 69853-69854]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27926]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Chronic Fatigue Syndrome Advisory Committee
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting of the Chronic Fatigue Syndrome Advisory Committee
(CFSAC) will take place via webinar. This webinar meeting will be open
to the public. The webinar will include public comment session(s).
Registration is required in advance for both public participants and
comment. Any individual who wishes to participate in the public meeting
and/or in the public comment session should register at
www.blsmeetings.net/CFSACdec2013/.
DATES: The webinar meeting will be held on Tuesday, December 10, 2013
and Wednesday, December 11, 2013 from 12:00 p.m. until 5:00 p.m. (EST)
on both days.
ADDRESSES: The meeting will be conducted by webinar.
FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, M.D., Designated Federal
Officer, Chronic Fatigue Syndrome Advisory Committee, Department of
Health and Human Services, Office on Women's Health, 200 Independence
Avenue SW., Room 712E, Washington, DC 20201. Phone: 202-690-7650; Fax:
202-401-4005. cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: The CFSAC is authorized under 42 U.S.C.
217a, Section 222 of the Public Health Service Act, as amended. The
purpose of the CFSAC is to provide advice and recommendations to the
Secretary of Health and Human Services, through the Assistant Secretary
for Health (ASH), on issues related to chronic fatigue syndrome (CFS).
The issues can include factors affecting access and care for persons
with CFS; the science and definition of CFS; and broader public health,
clinical, research and educational issues related to CFS.
[[Page 69854]]
The agenda for this meeting is being developed and will be posted
on the CFSAC Web site www.hhs.gov/advocomcfsac and at
www.blsmeetings.net/CFSACdec2013/. The webinar will be a ``virtual
meeting'' using Adobe Acrobat Connect Pro Meeting, a Web conferencing
product that allows users to conduct live meetings and presentations
over the Internet.
Using Adobe Connect Pro Meeting software requires that you have an
Internet connection, a Web browser, and the latest version of Adobe
Flash Player to participate in the webinar. Adobe Connect Pro is
supported by many operating systems, including Windows, Macintosh,
Linux, and Solaris as well as the most widely used browsers, including
Internet Explorer, Firefox, and Safari.
We recommend that you test your computer prior to participation.
You can do this by going to https://admin.adobeconnect.com/common/help/en/support/meeting_test.htm. Instructions for accessing the webinar
will be available at: www.blsmeetings.net/CFSACdec2013/webinarinformation.cfm.
This webinar will be limited to 500 participants. All individuals
who want to view the webinar will need to register. You will receive
instructions for accessing the webinar after you register. Members of
the public will have the opportunity to provide public comment during
the meeting via telephone, pre-recorded video, or written comments.
Registration is required in advance in order to submit public comments.
An individual who would like to present comments should note this when
completing the registration form. The deadline to register and submit
public comments is Friday, November 29, 2013. We will confirm your time
for public comment via email by December 4, 2013. Please refer to the
agenda for scheduled public comment periods. Each speaker via telephone
or pre-recorded video will be limited to five minutes. We will give
priority to individuals who have not provided public comment within the
past 12 months. We will be unable to place international calls for
public comments. We can accept written or prerecorded video testimony
from international locations. Further details are available at
www.blsmeetings.net/CFSACdec2013/publicComments.cfm.
Only testimony submitted for public comment and received in advance
of the meeting are part of the official meeting record and will be
posted to the CFSAC Web site. Materials submitted should not include
sensitive personal information, such as social security number,
birthdates, driver's license number, state identification or foreign
country equivalent, passport number, financial account number, or
credit or debit card number. If you wish to remain anonymous the
document must specify this.
Dated: November 18, 2013.
Nancy C. Lee,
Designated Federal Officer, Chronic Fatigue Syndrome Advisory
Committee, U.S. Department of Health and Human Services.
[FR Doc. 2013-27926 Filed 11-20-13; 8:45 am]
BILLING CODE 4150-42-P